| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |